SLC2A1 and breast cancer: Among the many immunohistochemical indicators of hypoxia, GLUT1 is overwhelmingly expressed in breast cancer but its expression is extremely rare in benign breast lesions such as ductal hyperplasia or atypical ductal hyperplasia.